Last updated on May 2019

ADAPT - A Patient Registry of the Real-world Use of Orenitram

Brief description of study

This prospective, observational, multicenter, patient registry will follow patients who are receiving treatment with Orenitram for the treatment of PAH for up to 78 weeks from Orenitram initiation

Clinical Study Identifier: NCT03045029

Find a site near you

Start Over

Anderson Pharmaceutical Research, LLC

Anderson, SC United States
  Connect »